- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Two New Symptoms That Could Point to Pancreatic Cancer
Researchers have identified two previously unrecognized symptoms of pancreatic cancer — a discovery that might help with earlier detection and improve extremely low survival numbers, they say.
“When pancreatic cancer is diagnosed earlier, patients have a higher chance of survival. It is possible to diagnose patients when they visit their GP, but both patients and GPs need to be aware of the symptoms associated with pancreatic cancer,” said study author Weiqi Liao, a data scientist at Britain’s University of Oxford.
Along with confirming 21 previously identified signs of pancreatic cancer, the new study pinpoints two new symptoms — feeling thirsty and having dark urine — associated with the deadly disease.
It also shows that patients often have some symptoms of the disease up to a year before their diagnosis, and other significant symptoms three months before diagnosis.
Most pancreatic cancer patients are diagnosed at a late stage and the disease has the lowest survival numbers among all common cancers. In the United States, the five-year survival rate for pancreatic cancer patients is about 10%, according to the American Cancer Society.
The study included more than 24,000 patients who were diagnosed with pancreatic cancer in England between 2000 and 2017.
Yellowing of the skin (jaundice) and bleeding in the stomach or intestine were the two serious symptoms most associated with pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, and pancreatic neuroendocrine neoplasms (PNEN), a rarer form of pancreatic cancer.
The two newly identified symptoms — thirst and dark urine — were associated with PDAC, according to the study. The results were presented virtually Monday at a U.K. National Cancer Research Institute meeting.
Other symptoms linked with PDAC include: problems swallowing, diarrhea, change in bowel habits, vomiting, indigestion, abdominal mass, abdominal pain, weight loss, constipation, fat in stool, abdominal swelling, nausea, flatulence, heartburn, fever, tiredness, appetite loss, itching and back pain.
Other symptoms associated with PNEN include: diarrhea, change in bowel habits, vomiting, indigestion, abdominal mass, abdominal pain and weight loss.
“These new findings enable us to conduct further work on understanding symptoms that could suggest pancreatic cancer. This will help GPs to make decisions about who to refer for urgent tests, especially when patients have several seemingly non-specific symptoms,” Liao said in an institute news release.
Studies presented at meetings are typically considered preliminary until published in a peer-reviewed medical journal.
More information
The American Cancer Society has more on pancreatic cancer.
SOURCE: National Cancer Research Institute, news release, Nov. 8, 2021
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.